| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |